Vaccines

Publication Date	March 2008
Publisher	Cygnus
Product Type	Report
Pages	143
ISBN Number	not applicable
Product Code	CYG00064

Price

£600.00
approximately: $1,121 | €761

PDF

Order above formats by FAX

Summary

Vaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand. While governments are reluctant to ensure steady demand for vaccines unless the manufacturers can prove their ability to increase their supply, the latter are apprehensive about increasing production without a guarantee of sustained demand from the governments. Meanwhile, developing nations are increasingly demanding vaccines that are no longer included in the immunization schedules of developed countries. These vaccines will have to be provided at very low costs, which will not be feasible unless the demand can compensate for the low margins. Global vaccines market is estimated at USD10 billion in 2007; human vaccine valued at USD8.3 billion contributes major share ie 83% of the total market and rest 17% is occupied by animal vaccine valued at USD1.7 billion. The US is the leading market, accounting for more than 50% of the global vaccine market. Influenza vaccine is the fastest growing in the adult vaccine segment followed by Hepatitis vaccines.The vaccines market in India in 2006-07 was INR30.53 billion registering a 30.41% growth over the previous year. India's huge population makes it among the world's largest market for vaccines of all types. India faces a growing demand for new generation and 'combination' vaccines, such as DPT with Hepatitis B, Hepatitis A and Injectable polio vaccine, besides several veterinary and poultry vaccines. Indian vaccines market is dominated by paediatric vaccine with 60% of market share. Combination vaccines are driving the growth of vaccine market in India.

Industry Insight - Vaccines report is prepared keeping in mind the current growth in demand for vaccines in India.The report attempts to cover the industry with a perspective of global vaccines market, segments and its growth in demand.

A market assessment of vaccines segment with reference to the market size and market trend is presented.
Vaccines report presents the growth drivers such as increasing population, disease awareness etc.
It presents the issues and challenges involved in vaccines with reference to vaccine funding, timely regulatory clearance.
It provides information on the critical success factors such as pricing, government programmes etc o 10 Major players have been profiled providing introduction, financial, operational details of the company.
The report presents a brief outlook about the regulatory issues and also the regulatory aspects involved in vaccines segment.
The report provides a future outlook of vaccines market.

Content

1. Introduction
2. Market Overview
- 2.1 Global Market Overview
  - 2.1.1 Introduction
  - 2.1.2 Market Scenario
    - 2.1.2.1market Segmentation
    - 2.1.2.2 Market Trends
    - 2.1.2.3 Major Players
  - 2.1.3 Major Markets
    - 2.1.3.1 Usa
    - 2.1.3.2 Europe
  - 2.1.4 Outlook
- 2.2 Indian Market Overview
  - 2.2.1 Introduction
  - 2.2.2 Current Market Scenario
    - 2.2.2.2 Market Size
    - 2.2.2.1 Market Segment
    - 2.2.2.3 Market Trends
  - 2.2.3 Outlook 40 3 Growth Drivers
- 3.1 Increasing Population In Developing Countries
- 3.3 Diseases Prevention
- 3.4 Blockbuster Potential Of New Vaccines
- 3.5 Disease Awareness
- 3.6 India - Future Hub For Paediatric Vaccine Manufacturing
4. Issues And Challenges
- 4.1 Vaccine Funding
- 4.2 Lack Of Infrastructure For Trials & Manufactures
- 4.3 Dependence On Government By Domestic Companies
- 4.4 Timely Regulatory Clearance
- 4.5 Vaccine Supply 48 5 Critical Success Factors
- 5.1 Pricing
- 5.2 Funding From Government & Ngos
- 5.3 Distribution Network
- 5.4 Government Immunisation Programme
- 5.5 Storage Infrastructure
6. Major Players
- 6.1 Serum Institute Of India Ltd
- 6.2 Panacea Biotech Ltd
- 6.3 Venkateshwara Hatcheries Private Ltd
- 6.4 Indian Immunological Ltd
- 6.5 Glaxosmithkline Pharmaceuticals Ltd
- 6.6 Aventis Pharma Limited
- 6.7 Shantha Biotechnics
- 6.8 Eli Lilly India
- 6.9 Haffkine Bio Pharmaceutical Corporation Ltd (Hbcl)
- 6.10 Intervet India
7. Regulatory Environment
- 7.1 U.S.A
- 7.2 Europe
- 7.3 India
8. Future Outlook
List Of Tables
- Table 2.1: Global Vaccine Companies Revenue
- Table 2.2: Key Alliances Of Sanofi-Aventis
- Table 2.3: R&D Pipeline Of Sanofi-Aventis
- Table 2.4: Segmental Revenue In Biopharma Sector
- Table 2.5: Products Segment In The Vaccine Market
- Table 2.6: Top Ten Vaccine Players In India
- Table 2.7: Major Vaccines
- Table 2.8: Vaccines Launched In India
- Table 3.1: Combination Of Vaccines
- Table 3.2: New Combination Of Vaccines
- Table 6.1: Top Ten Players In India Biopharma Sector
- Table 7.1: Some Bio Piracy Patents Based On Indigenous Knowledge Of India
List Of Figures
- Figure 2.1: Geographical Segments Of Vaccine Markets
- Figure 2.2: Global Vaccine Market
- Figure 2.3 Sanofi-Aventis Vaccine Segment
- Figure 2.4: Glaxo Smith Kline Vaccine Segment
- Figure 2.5: Novartis Vaccine Segment Region Wise
- Figure 2.6: Merck Vaccine Segment
- Figure 2.7: Segment Wise Biopharma Sales Contribution
- Figure 2.8: Segment Wise Biopharma Sales Contribution
- Figure 2.9: Indian Vaccine Market
- Figure 2.10: Segment Wise Contribution In The Animal Vaccine Market
- Figure 2.11: Major Players In Indian Poultry Vaccine Market
- Figure 8.1: Indian Biopharmaceutical Market Forecast
- Figure 8.2 Indian Vaccine Market Forecast